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Methodology in the stratification of surgical risk 
allows us to design predictive models based on the 
patient’s variables that will allow us to stratify them 
according to surgical risk. The additive EuroSCORE 
risk model was developed based on 19,030 patients 
from 128 hospitals in eight European countries who 
underwent cardiac surgery between September and 
November 1995 [1]. Ninety-seven risk factors were 
studied and, of those, 17 were identified as being 
significantly associated with increased surgical 
mortality. The additive EuroSCORE overpredicts 
risk in coronary and valvular surgery, underpredicts 
observed mortality for combined valve and coronary 
surgery and has poor predictive ability for patients 
at higher risk [2].
The logistic EuroSCORE, published in 2003, 
uses a more complex algorithm to be a better 
predictor than the additive model, using the same 
preoperative risk factors [3]. It has been shown to 
be a better predictor than the additive EuroSCORE 
for high-risk patients, but continues to overesti-
mate mortality by a factor of approximately 2.5 
in the 6 risk classes in European, American and 
Australian studies [2, 4]. These results have been 
associated to improvements in surgical techniques 
and perioperative care which results in a reduction 
of hospital mortality. These results reinforce the 
hypothesis that patients who would have died one 
or two decades ago, currently survive thanks to 
improved perioperative care.
The update to EuroSCORE II is based on 
23,000 patients having undergone cardiac surgery 
in 150 hospitals in 43 countries between May 
and July 2010 [5]. EuroSCORE II has improved 
risk prediction in combined aortic valve replace-
ment and high-risk patients. However, it is poorly 
calibrated in the lowest-risk patients. In isolated 
coronary bypass surgery, it has been published 
that the original EuroSCORE has a better fit than 
EuroSCORE II, raising concerns over its replace-
ment [6, 7].
Nevertheless, the EuroSCORE and other risk 
models have certain limitations in terms of the 
stratification of surgical risk:
 — The result, or dependent variable, is hospital 
mortality. Other relevant aspects, such as pre-
dicting complications during surgery, the dura-
tion of post-operative hospital stay, perceived 
quality by the patient, functional class and 
quality of life, are not measured as dependent 
variables. The EuroSCORE observes only 
a short and possibly biased interval. The wrong 
or incomplete therapeutic process could be 
associated with differences in short- and long-
-term outcomes. The time-spans in the evalu-
ation of outcomes are often under measured.
 — The majority of the risk stratification models 
are static. The information was obtained in 
a determinant moment, the model was de-
veloped and then validated a posteriori. This 
can lead to the overestimation of risk using 
EuroSCORE. One of the advantages of The 
National Database of the Society of Thoracic 
Surgeons is that it is updated annually, and 
from the operative point of view, it is the 
optimal system.
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 — The potential part of subjectivity in the encod-
ing method inside the EuroSCORE and its 
possible impact on the score’s predictive power 
has been investigated. The inter-observer dis-
crepancies, between surgeon and perfusionist 
were observed in 26% of patients [8]. As sur-
geon prediction value was more often superior 
to perfusionist value than the reverse, one may 
hypothesize that surgeon attempted to game 
the scoring system. Factors relevant to Euro-
SCORE (ejection fraction, serum creatinine lev-
els and pulmonary systolic pressure) may vary 
as a result of medical preoperative treatment. 
Any of these variables may also vary according 
to which imaging tests are used to measure for 
example the ejection fraction (echocardiogra-
phy vs. angiography). Some definitions may still 
give room for error by interpretation. Another 
aspect is the codification of the procedure. In 
the case of aortic valve replacement, where 
an aortic patch is used to enlarge the aortic 
annulus or the aortotomy, is it to be consid-
ered surgery of the thoracic aorta? There is 
some disagreement among observers about 
the scoring of unstable and recent myocardial 
infarction, probably as a result of changes in the 
international definition of myocardial infarction 
and unstable angina in the new overall concept 
of acute coronary syndromes.
 — Risk factors that are known to affect mortality, 
such as hepatic cirrhosis or mediastinal radio-
therapy, are not included in the dataset. Medi-
cal conditions affecting mobility are included 
in EuroSCORE II under the factor “poor 
mobility” [6]. However, medical conditions 
that do not affect mobility are not included. 
Anatomical features like the degree of aortic 
calcification or an incomplete revasculariza-
tion neither are included. The SYNTAX study 
(synergy between percutaneous coronary 
intervention with Taxus and cardiac surgery), 
includes a score based on the characteristics 
of the coronary lesions, such as calcification, 
total occlusion and coronary arteries of less 
than 2.5 mm [9].
 — EuroSCORE has been used to compare con-
ventional surgery with alternative procedures, 
like percutaneous coronary interventions or 
trans-aortic valve implantation [10]. Over-
prediction of mortality and the absence of 
long-term evaluation can lead to mistaken 
decisions to opt for alternative procedures.
In the past, the use of a score for the evaluation 
of the practices in cardiac surgery had an impact on 
how users encoded. The most publicized example 
was the logistic model of the New York State in 
the 1990s, which published the ranking of cardiac 
surgeons in New York Times. A shift in patient 
risk profile was observed for some surgeons, who 
improved by the way, their ranking [8]. Risk strati-
fication is essential for the monitoring of surgeons 
and hospitals. Reliance on a risk stratification 
system that over-predicts mortality may have 
serious consequences. It leads to a false sense of 
reassurance, underperformance may be undetected 
and patient welfare may be compromised [2]. On 
the other hand, surgeons may reject the indication 
of surgery in high-risk patients because of factors 
not included in the EuroSCORE dataset.
In this issue of “Cardiology Journal”, the Hos-
pital de Clínicas of Buenos Aires group [11] publish-
es a validation of EuroSCORE II in low- and very-
low-risk patients. A validation of EuroSCORE II 
in this group of patients is very interesting because 
it has been less studied than in high-risk patients. 
In the group of patients with low mortality, in order 
to be able to establish a validation, it is necessary to 
have a very large sample. Furthermore, this group 
tends to be patients with ischemic cardiopathy. 
The authors conclude that this risk model proved 
to be useful in evaluating the quality standards of 
local cardiac surgery, and that the review of cases 
of deaths provides valuable information for improv-
ing quality of care. Precision in the prediction of 
surgical risk is a tool which, though it may not offer 
results in the medium- to long-term, and does not 
take into account the anatomic characteristics of 
the coronary lesion, may, nevertheless, aid better 
therapeutic decision-making when deciding be-
tween coronary surgery and percutaneous coronary 
intervention.
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